Ferritin and breast cancer
Claustres, M.; Belaroussi, N.; Guilleux, F.; Magnan de Bornier, B.
Pathologie-Biologie 32(4): 265-268
1984
ISSN/ISBN: 0369-8114 PMID: 6718068 Document Number: 226491
Studies of human breast cancers show that tumoral tissues have a much higher ferritin content (mean : 4,5 times) than normal tissues. However, only 10% of patients without metastasis present raised levels of serum ferritin, whereas hyperferritinemia is observed in almost 95% of patients with liver, bone or lung metastasis.
Document emailed within 1 workday
Related Documents
Rusinowska, Z.; Rozek-Lesiak, K.; Kokocińska, D. 1988: Serum ferritin level in patients with breast cancer Polski Tygodnik Lekarski 43(22): 706-708Chekhun, S.V.; Lukyanova, N.Y.; Shvets, Y.V.; Burlaka, A.P.; Buchinska, L.G. 2014: Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells Experimental Oncology 36(3): 179-183
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Zannino, L.; Rovere, A.; Nebiolo, F.; Lievore, L.; Gomirato, G. 1982: Study of serum ferritin in a population of 3-month-old breast feeding children La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 4(3): 287-290
Sebestík, V.; Feyereislová, A.; Sejkorová, J.; Friedmann, B.; Neuwirt, J. 1990: Examination of serum ferritin and erythrocyte ferritin--its role in the blood transfusion service Folia Haematologica 117(1): 185-191
Chen, L.L.; Wang, S.T.; Chen, S.S. 1987: Clinical significance of serum ferritin and leukocyte ferritin estimation in adult leukemias Chinese Medical Journal 100(1): 63-67
Nakajima, S.; Kojima, Y.; Ito, T. 1970: Non-crystallizable ferritin. II. Comparison between ferritin and hemosiderin at the subunit level Seikagaku. Journal of Japanese Biochemical Society 42(5): 248-254
König, B.; Oed, M.; Kunz, A.; Schlett, R.; Mack, M. 1999: LIAISON Ferritin--an automated chemiluminescent immunoassay for the determination of Ferritin Anticancer Research 19(4a): 2739-2741
Eourrier, F.; Kadouche, J.; Brisson, C.; Mignot, L.; Najean, Y. 1983: Initial evaluation and monitoring of breast cancers. Value of assaying carcinoembryonic antigen, ferritin, and beta-2-microglobulin Presse Medicale 12(12): 765
Reiner, A.S.; Sisti, J.; John, E.M.; Lynch, C.F.; Brooks, J.D.; Mellemkjær, L.; Boice, J.D.; Knight, J.A.; Concannon, P.; Capanu, M.; Tischkowitz, M.; Robson, M.; Liang, X.; Woods, M.; Conti, D.V.; Duggan, D.; Shore, R.; Stram, D.O.; Thomas, D.C.; Malone, K.E.; Bernstein, L.; Bernstein, J.L. 2018: Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 36(15): 1513-1520
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Mariuzzi, L.; Mombello, A.; Rucco, V.; Morelli, L.; Zamò, A.; Thompson, D.; Vaught, L.; Bartels, H.G.; Mariuzzi, G.; Bartels, P.H. 2000: Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer Advances in Clinical Pathology: the Official Journal of Adriatic Society of Pathology 4(2): 87-97
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Micheel, B. 1970: Ferritin labeled antibodies and their use in experimental cancer research Archiv für Geschwulstforschung 36(2): 171-184
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560